Cravath Representes AmerisourceBergen in Acquisition of PharMEDium
By Lawdragon News | October 6, 2015 | Press Releases
October 6, 2015 — AmerisourceBergen today announced that it has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, Inc., the privately held leading national provider of outsourced compounded sterile preparations to acute care hospitals in the United States, for $2.575 billion in cash, subject to certain adjustments and on a cash-free, debt-free basis. Cravath, Swaine & Moore LLP is representing AmerisourceBergen in connection with this transaction.
The Cravath team is being led by partners Damien R. Zoubek and Robert I. Townsend III and includes associates Eric M. Wasserstrum and Matthew J. Aldana and foreign associate attorney Tomas E. Di Cio (M&A); partner J. Leonard Teti II and associate Tara L. Rhoades (tax); partner Eric W. Hilfers and associate Matthew Cantor (executive compensation and benefits); partner Matthew Morreale (environmental); and partner David J. Kappos and practice area attorney Anthony N. Magistrale (intellectual property). Brian B. Kennedy also worked on executive compensation and benefits matters.
